Hereditary disorders of fibrinogen

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 65-88

  Matsuda, Michio ^a   Sugo, Teruko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Fibrin polymerization; Fibrinogen; Functional abnormality; Hereditary dysfibrinogen; Ultrastructure of fibrin clot

Indexed keywords

FIBRIN; FIBRINOGEN; GLYCYLPROLYLARGININE; INTEGRIN; PLASMIN; PLASMINOGEN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRIPEPTIDE; UNCLASSIFIED DRUG;

BINDING SITE; CONFERENCE PAPER; CRYSTALLOGRAPHY; DISULFIDE BOND; FIBRIN CLOT; FIBRIN POLYMERIZATION; FIBRINOGEN DEFECT; FIBRINOLYSIS; GENETIC DISORDER; HUMAN; KIDNEY AMYLOIDOSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0034969432     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03494.x     Document Type: Conference Paper

References (98)

1. The covalent structure of human fibrinogen
2. Fibrinogen and fibrin
3. Lateral aggregation and the role of the two pairs of fibrinopeptides
4. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots
5. Role of the αC domains of fibrin in clot formation
6. Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization
7. Evidence for a second type of fibrin branch point in fibrin polymer networks, the trimolecular branch junction
8. Three-dimensional reconstruction of fibrin clot networks from stereoscopic intermediate voltage electron microscopic images and analysis of branching
9. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen
10. The fibrin polymerization pocket: Three-dimensional structure of a 30 kDA C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro
11. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin
12. The polymerization pocket 'a' within the carboxyl-terminal region of the γ chain of human fibrinogen is adjacent to but independent from the calcium-binding site
13. A three dimensional consideration of varian human fibrinogens
14. The elucidation of molecular defects in congenital dysfibrinogenemia
15. Fibrinogen Mitaka II: A hereditary dysfibrinogen with defective thrombin binding caused by an Aα Glu-11 to Gly substitution
16. The structure of residues 7-16 of the Aα-chain of human fibrinogen bound to bovine thrombin at 2.3-Å resolution
17. The interaction of thrombin with fibrinogen. A structural basis for its specificity
18. Thrombin hydrolysis of an N-terminal peptide from fibrinogen Lille: Kinetic and NMR studies
19. Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-Aα16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue
20. Genetically abnormal fibrinogens - Strategies for structure elucidation, including fibrinopeptide analysis
21. Molecular abnormalities of fibrinogen - The present status of structure elucidation
22. Inherited dysfibrinogenemia: Emerging abnormal structure associations with pathologic and nonpathologic dysfunctions
23. The structure-function relationship of hereditary dysfibrinogens
24. The molecular defect of the genetically abnormal fibrinogen Christchurch II
25. Evidence for localization of polymerization sites in fibrinogen
26. Evidence for four different polymerization sites involved in human fibrin formation
27. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (γ 275 Arg→Cys)
28. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers
29. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences
30. A new type of congenital dysfibrinogen, fibrinogen Bremen, with an Aα Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing
31. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of Aα proline-18 by leucine
32. Fibrinogen Kanazawa: A congenital dysfibrinogenemia with delayed polymerization having a replacement of proline-18 by leucine in the Aα-chain
33. Fibrinogen Detroit-A molecular defect in the N-terminal disulphide knot of human fibrinogen?
34. Fibrinogen Aarhus - A new case of dysfibrinogenemia
35. Fibrinogen Mannheim I-identification of an Aα 19 Arg→Gly substitution in dysfibrinogenemia associated with bleeding tendency
36. Fibrinogen Kumamoto with an Aα Arg-19 to Gly substitution has reduced affinity for thrombin: Possible relevance to thrombosis
37. Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the γ-chain that impairs the polymerization of fibrin monomer
38. Characterization of fibrinogen Milano I: Amino acid exchange γ 330 Asp→Val impairs fibrin polymerization
39. Fibrinogen Kyoto III: A congenital dysfibrinogen with a γ aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization
40. Fibrinogen Matsumoto I: A γ 364 Asp→His (GAT→CAT) substitution associated with defective fibrin polymerization
41. Association of dysfibrinogenemia and thrombosis. Apropos of a family (fibrinogen Melun) and review of the literature
42. γ-chain dysfibrinogenemias: Molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen
43. Characterization of an abnormal fibrinogen Osaka V with the replacement of γ-arginine 375 by glycine
44. Fibrinogen Bern I: Substitution γ 337 Asn→Lys is responsible for defective fibrin monomer polymerization
45. A new substitution, γ 358 Ser→Cys, in fibrinogen Milano VII causes defective fibrin polymerization
46. "Fibrinogen Tokyo II": An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules
47. Substitution of γ Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site
48. Three abnormal fibrinogen variants with the same amino acid substitution (γ 275 Arg→His): Fibrinogens Bergamo II, Essen and Perugia
49. Normal plasmic cleavage of the γ chain variant of "fibrinogen Saga" with an Arg-275 to His substitution
50. A new type of Ser substitution for γ Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly
51. Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (γ 280 Tyr→Cys): A new variant with defective polymerization
52. A γ Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I
53. 1 by plasmin and the generation of a new plasmin cleavage site
54. Polymerization defect of fibrinogen Baltimore III due to a gamma Asn-308→Ile mutation
55. A γ methionine-310 to threonine substitution and consequent N- glycosylation at γ asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi
56. Carbohydrate structure of human fibrinogen
57. End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure
58. Fibrinogen Marburg: A homozygous case of dysfibrinogenemia, lacking amino acids Aα 461-610 (Lys 461 AAA→Stop TAA)
59. Factor XIIIa-cross-linking of the Marburg Fibrin: Formation of αm·γn-heteromultimers and the α-chain-linked albumin·γ complex, and disturbed protofibril assembly resulting in acquisition of plasmin-resistance relevant to thrombophilia
60. Molecular basis for fibrinogen Dusart (Aα 554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophilia
61. A correlation between thrombotic disease and a specific fibrinogen abnormality (Aα 554 Arg→Cys) in two unrelated kindred, Dusart and Chapel Hill III
62. An Aα Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation
63. Fibrinogen Dusart: Electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots
64. The relationship between the fibrinogen D domain self-association/cross-linking site (γXL) and the fibrinogen Dusart abnormality (Aα R554C-albumin). Clues to thrombophilia in the "Dusart syndrome"
65. The ultrastructure of fibrinogen Caracas II molecules, fibers and clots
66. Fibrinogen Lima: A homozygous dysfibrinogen with an Aα-arginine-141 to serine substitution associated with extra N-glycosylation at Aα-asparagine-139
67. Fibrinogen Kaiserslautern (γ 380 Lys to Asn): A new glycosylated fibrinogen variant with delayed polymerization
68. The binding of calcium to bovine fibrinogen
69. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments
70. Localization of a fibrinogen calcium binding site between γ-subunit positions 311 and 336 by terbium fluorescence
71. The binding of thrombin to fibrin
72. Fibrinogen Milano II: A congenital dysfibrinogenemia associated with juvenile arterial and venous thrombosis
73. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator
74. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator
75. The binding of human plasminogen to fibrin and fibrinogen
76. Location of plasminogen binding sites in fibrin(ogen)
77. Gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors
78. Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping principle
79. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding
80. Adsorptive endocytosis of fibrin monomer by macrophages: Evidence of a receptor for the amino terminus of the fibrin α chain
81. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the γ chain gene, causing defective calcium binding and impaired fibrin polymerization
82. Characterization of fibrinogen New York I. A dysfunctional fibrinogen with a deletion of Bβ (9-72) corresponding exactly to exon 2 of the gene
83. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bβ 68 Ala→Thr
84. Fibrinogen lysine residue Aα 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator
85. Localization in the fibrinogen γ-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalyzed activation of plasminogen
86. A new type of congenital dysfibrinogenemia with defective fibrin lysis - Dusard syndrome: Possible relation to thrombosis
87. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation
88. Dysfibrinogenemia (Fibrinogen Dusart) associated with impaired fibrin-enhanced plasminogen activation
89. Hereditary dysfibrinogenemia in a patient with thrombotic disease
90. 3 on their surface
91. Hereditary renal amyloidosis associated with a mutant fibrinogen α-chain
92. Hereditary renal amyloidosis with a novel variant fibrinogen
93. The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindreds
94. A frame shift mutation in the fibrinogen Aα chain gene in a kindred with renal amyloidosis
95. Renal amyloidosis with a frame shift mutation in fibrinogen Aα-chain gene producing a novel amyloid protein
96. Structure and function of fibrinogen: Insights from dysfibrinogens
97. Structure and function of fibrinogen inferred from hereditary dysfibrinogens